Perrigo Company plc (PRGO)

IE — Healthcare Sector
Peers: RDY  PBH  COLL  XRAY  UHS  RMD  COR  HSIC 

Automate Your Wheel Strategy on PRGO

With Tiblio's Option Bot, you can configure your own wheel strategy including PRGO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PRGO
  • Rev/Share 31.4844
  • Book/Share 31.6921
  • PB 0.8415
  • Debt/Equity 0.8312
  • CurrentRatio 2.3589
  • ROIC -0.2216

 

  • MktCap 3666511590.0
  • FreeCF/Share 1.3152
  • PFCF 20.2458
  • PE -20.6783
  • Debt/Assets 0.3717
  • DivYield 0.0424
  • ROE -0.0399

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade PRGO Argus Buy Hold -- -- Jan. 14, 2025
Downgrade PRGO Piper Sandler Overweight Neutral $34 $27 Jan. 6, 2025
Resumed PRGO Jefferies -- Hold $50 $30 Sept. 24, 2024

News

Perrigo Increases Quarterly Dividend by 5%
PRGO
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN , Feb. 19, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors has approved a 5% increase in the Company's quarterly dividend to $0.290 per share, or $1.16 per share on an annual basis, up from $0.276 per share. This marks the 22nd consecutive year Perrigo has increased its dividend.

Read More
image for news Perrigo Increases Quarterly Dividend by 5%

About Perrigo Company plc (PRGO)

  • IPO Date 1991-12-17
  • Website https://www.perrigo.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Patrick Lockwood-Taylor
  • Employees 8379

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.